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An Integrative Common Liabilities Model for the Comorbidity of Substance Use Disorders with
Externalizing and Internalizing Disorders
Erin C. Tully
William G. Iacono
University of Minnesota

Abstract
This paper presents an integrative research-derived model to explain comorbidity among SUDs,
externalizing disorders, and internalizing disorders. This hierarchical model is based on
phenotypic covariance among the disorders and latent common genetic liability. At the highest
level of the hierarchy, general genetically-influenced biological dispositions to negative
emotionality and behavioral disinhibition each give rise to spectra of related personality traits,
cognitive processes, behavioral tendencies, and psychopathology that account for the pattern of
co-occurrence among mental disorders. At the lowest level of the hierarchy, disorder-specific
genetic and environmental effects explain the presence of some and not other disorders
associated with a given general liability. Interplay between the general liabilities and both other
genes and environmental factors throughout development affect the likelihood of developing
specific mental disorders.
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1. Introduction
Comorbidity, or the tendency for disorders to co-occur at greater than chance rates
(Clark, Watson, & Reynolds, 1995), is high among psychiatric disorders, with estimates that
nearly 60% of individuals with a lifetime DSM-IV psychiatric disorder have diagnoses of more
than one disorder (Kessler, Berglund, Demler, Jin, & Walters, 2005). Drug and alcohol use
disorders are frequently comorbid with each other, and rates of substance use disorders (SUDs)
are nearly three times as common among individuals with psychiatric disorders compared to
individuals with no psychiatric disorder (Regier et al., 1990). Estimates from the National
Comorbidity Survey-Replication (NCS-R) study indicate that SUDs are comorbid with antisocial
disorders, mood disorders, and anxiety disorders. The likelihood of having a SUD was increased
by six times among individuals with Conduct Disorder (CD; Nock, Kazdin, Hiripi, & Kessler,
2006), and last 12-month diagnoses of SUDs were about six to seven times more common
among individuals with Antisocial Personality Disorders (ASPD; Lenzenweger, Lane, Loranger,
& Kessler, 2007). Twenty-four percent of individuals with lifetime major depressive disorder
(MDD) had a lifetime SUD diagnosis (Kessler et al., 2003), compared to lifetime estimates of
14.6% for SUDs in the general population (Kessler et al., 2005). The likelihood of having a SUD
was 2.2 to 4.8 times greater among individuals with panic disorders (PD) and/or agoraphobia
(Ago; Kessler et al., 2006), and subsequent SUDs were about twice as likely for individuals with
Generalized Anxiety Disorder (GAD; Ruscio et al., 2007).
A great deal is known about the etiology of SUDs, including the typical developmental
progression from behavioral and neurobiological predispositions to the emergence of SUDs
during adolescence and early adulthood and the importance of both genetic and environmental
influences on risk for SUDs. Considerably less is known about the origins of comorbidity with
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SUDs. This chapter provides a comprehensive review of the literature and describes an
integrative model (Figure 1) to explain comorbidity among SUDs and other common mental
disorders. The model is based on three central principles: (1) risk for psychopathology is
multifactorial, reflecting cumulative effects of gene-environment interplay that begins in
childhood and early adolescence, (2) covariance among common mental disorders is captured by
two broad hierarchically organized dimensions characterized by externalizing and internalizing
tendencies, and (3) the organization of this hierarchical system derives from genetically
influenced biological dispositions to negative emotionality and at a lower level of the hierarchy
to behavioral disinhibition, negative thought processes, and physiological hyperarousal. Our
main thesis is that comorbidity can largely be explained by genetic liabilities for biological
processes that give rise to these externalizing and internalizing dimensions, each of which is
composed of related personality traits, cognitive processes, behavioral tendencies, and symptoms
of psychopathology. In the sections that follow, we review empirical and theoretical support for
this model from a developmental perspective and then describe how the model explains the
comorbidity of SUDs with other psychiatric disorders. We begin by reviewing research on the
underlying covariance structure of psychopathology, which forms the basis for the hierarchical
common liabilities model.
2. Common Genetic Liabilities
The high comorbidity among psychiatric disorders suggests that psychopathology is
encompassed by a smaller number of higher order constructs. Multivariate twin studies have
modeled the covariance of depression, anxiety, substance use, and antisocial disorders to identify
the latent structure underlying comorbidity. In these studies, the amount of genetic influence
shared among different disorders is calculated by comparing monozygotic and dizygotic twin
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pairs on the degree of association between a phenotype (e.g., alcohol dependence) in one twin
and a different phenotype (e.g., ASPD) in the co-twin. Shared genetic influences can be inferred
when monozygotic twins have greater cross-phenotype similarity than dizygotic twins.
A meta-analysis of these multivariate studies (Krueger & Markon, 2006) revealed a bestfitting model with two correlated superordinate factors underlying two broad spectra of
disorders: (a) an externalizing (EXT) spectrum/factor that encompasses antisocial deviance (i.e.,
CD and ASPD) and substance abuse/dependence and is described as the propensity to express
distress outward, and (b) an internalizing (INT) spectrum/factor that encompasses depressive
(MDD and dysthymia) and anxiety disorders (GAD, phobias, PD) and is described as a
propensity to express distress inward. In the best-fitting model, this INT factor was further
subdivided into two highly correlated but distinct subfactors. One INT factor, which we have
labeled anhedonia/misery (INT-AM), underlies the covariance of MDD, persistent depressive
disorder (formerly dysthymic disorder), and GAD; and the second INT factor, which we have
labeled fear/arousal (INT-FA), underlies agoraphobia, social anxiety disorder, specific phobia,
and panic disorder.1 PD had a modest loading on the INT-AM factor as well, and given that other
large multivariate twin studies (e.g., Kendler, Prescott, Myers, & Neale, 2003) find that PD loads
more strongly onto a factor with MDD and GAD, PD is depicted with loadings on both INT
subfactors in our common liabilities model.
Twin and adoption studies support the substantial role of genes in the etiology of mental
disorders. In childhood and early adolescence, genes contribute to individual differences in traits
like aggression, inattention, and fearfulness (Bartels et al., 2007; Hirata, Zai, Nowrouzi,
Beitchman, & Kennedy; 2013; Trzaskowski, Zavos, Haworth, Plomin, & Eley, 2012;
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Zai, Ehtesham, Choi, Nowrouzi, de Luca, Stankovich, et al., 2012), which are predictive of
psychopathology later in adolescence and adulthood (e.g., Ormel et al., 2005; Pardini, Lochman,
& Wells, 2004). Genetic factors contribute to disruptive behavior disorders, anxiety disorders,
and depressive disorders in youth (Ehringer, Rhee, Young, Corley, & Hewitt, 2006), and by
adulthood, SUDs, antisocial behavior disorders, depressive disorders, and anxiety disorders are
at least moderately heritable (Fu et al., 2002; Goldman, Oroszi, & Ducci, 2005; Hettema,
Prescott, Myers, Neale, & Kendler, 2005; Sullivan, Neale, & Kendler, 2000; Tully, Iacono,
McGue, 2010). The hierarchical INT/EXT structure suggests that disorders that load onto the
same factor share common core processes, and research suggests that these shared processes are
likely genetically influenced. Kendler et al.’s (2003) study showed that the distinction between
the INT and EXT factors was largely genetic rather than environmental in nature and that the two
INT subfactors had distinct, although positively correlated, genetic loadings (Kendler, Prescott,
Myers, & Neale, 2003).
Disorders are most highly comorbid with other disorders with loadings on the same factor
(Kessler et al., 2005). However, disorders that load onto different factors are also comorbid,
albeit to a lesser extent. This cross-factor comorbidity reflects the fact that the INT and EXT
factors are moderately correlated (r = .50; Krueger & Markon, 2006) and suggests shared
etiology of disorders across factors. In our common liabilities model, comorbidity of INT and
EXT disorders is largely explained by a general liability that influences risk for INT and EXT
disorders. The higher comorbidity of disorders loading on the same factor is explained by
additional genetic liabilities shared only among disorders of the EXT factor, the INT-AM
subfactor, or the INT-FA subfactor. Environmental factors are also proposed to contribute to the
etiology of mental disorders, and some environmental factors (e.g., high levels of stress) increase
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risk for various mental disorders and thus contribute to comorbidity. In addition, unique genetic
and environmental risks specific to each disorder account for multifinality (Cicchetti & Rogosch,
1996). In other words, they explain why individuals with the same general liability do not all
experience the same outcomes. We begin our discussion of common genetic liabilities with the
highest order liability that accounts for comorbidity across the INT and EXT factors.
2.1 Negative Emotionality Liability
Although best-fitting models from multivariate analyses of covariance identify two
higher order latent factors, the cross-factor comorbidity and correlation between the two factors
suggest the possibility of a higher order liability that influences disorders in both the INT and
EXT factors. We posit that comorbidity between SUDs and both externalizing and internalizing
psychopathology is due in part to a general, genetically influenced liability, which we have
labeled negative emotionality (NE). This general liability is expressed as a spectrum of
neurobiological processes, personality traits, and behavioral tendencies common to both INT and
EXT disorders, such as proneness to experiencing negative emotions like sadness and anger,
propensities toward inadequate emotion regulation abilities, and maladaptive responses to
negative emotions and stress.
Support for NE as a general liability is derived from findings of genetic influences on
variables related to the NE construct and from studies of NE-related personality traits underlying
both INT and EXT disorders. For example, neuroticism is a personality trait characterized by
emotional instability, vulnerability to stress, and proneness to anxiety (Eysenck, Eysenck, &
Barrett, 1985). Neuroticism is heritable (e.g., Birley et al., 2006) and has been associated with
depression and anxiety (Gershuny & Sher, 1998; Hettema, Neale, Myers, Prescott, & Kendler,
2006; Kendler, Gardner, & Prescott, 2002; 2006; Kendler, Gatz, Gardner, & Pedersen, 2006;
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Klein, Kotov, & Bufferd, 2011), antisocial behavior (Derefinko & Lynam, 2006; Hicks &
Patrick, 2006; Taylor, Reeves, James, & Bobadilla, 2006), and SUDs (Agrawal, Jacobson,
Prescott, & Kendler, 2004; Elkins, King, McGue, & Iacono, 2006; Jackson & Sher, 2003; Hur,
2009; James & Taylor, 2007; Miller, Vogt, Mozley, Kaloupek, & Keane, 2006). It has also been
found to account for a significant proportion of the comorbidity between INT and EXT disorders
(Khan, Jacobson, Gardner, Prescott, & Kendler, 2005). In addition, Tellegen (1982) proposed a
similar construct, also labeled negative emotionality, which is defined as a tendency to
experience negative emotions and to become behaviorally dysregulated under stress. Negative
emotionality prospectively predicts alcohol and marijuana dependence, CD, ASPD, depressive
disorders, and anxiety disorders (Krueger, 1999a; Slutske et al., 2002; Tellegen, 1982).
Research on endophenotypes provides further support for shared NE-related genetic
origins of INT and EXT disorders. Endophenotypes are attributes that are a product of genotypes
that predispose to a disorder and are presumed to be more proximal to the genetic influences than
clinical diagnoses themselves (Gottesman & Gould, 2003; Iacono & Malone, 2011). Disorders
associated with the same endophenotypes likely share some of the same genetic influences
(Yoon, Iacono, Malone, & McGue, 2006). Accurate identification of endophenotypes ultimately
requires research at the molecular level, but indices of biological processes (e.g.,
psychophysiology measures, levels of hormones and neurotransmitters) that are correlated with
clinically relevant phenotypes and genetically influenced are plausible endophenotypes. Many
neurobiological systems associated with NE, in particular anger and responses to stress are
common to both INT and EXT disorders. Corticotropin-releasing factor (CRF), the
hypothalamic-pituitary-adrenal (HPA) axis, and noradrenergic pathways are involved in the
body’s stress response system and have been implicated in the pathophysiology of anxiety,
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mood, and addictive disorders (for review see Brady & Sinha, 2005). Anger is largely regulated
by dopaminergic and glutamate systems in the nucleus accumbens and prefrontal cortex, and
neuroimaging and psychopharmacological treatment studies suggest that these systems also play
a role in the neurobiology of depressive, anxiety, behavioral, and SUDs (for reviews see Koob et
al., 2004; Lara & Akiskal, 2006). Moreover, serotonin, dopamine, and CRF have been implicated
in the etiology of substance-induced depression and anxiety (e.g., Markou , Kosten, & Koob,
1998; Rounsaville, 2004; Zoltgn et al., 1995), thus providing more evidence for common
endophenotypes for INT disorders and SUDs. The genetic basis of these neurobiological
substrates and systems is supported by association studies of candidate genes involved in the
stress response, particularly functional polymorphisms related to monoaminergic
neurotransmission (e.g., in the loci encoding the serotonin transporter, tyrosine hydroxylase,
catechol-o-methyltransferase, glucocorticoid receptor; for review see Levinson, 2006), and by
research on phenotypic outcomes resulting from modifications of serotonin-related genes in
rodents (for review see Holmes, 2008). These studies support the role of stress response
polymorphisms in the neurobiology of neuroticism (Levinson, 2006), depression (Brouwer et al.,
2006; Joensuu, et al., 2010; Levinson, 2006; Sarosi et al., 2008), and alcohol-related disorders
(Clarke et al., 2008; Florez et al., 2008; Merenäkk, et al., 2011).
Understanding how NE liability contributes to high co-occurrence among disorders
requires a developmental perspective. Trait negative emotionality is relatively stable from
infancy through adulthood (Lonigan, Phillips, & Hooe, 2003; Pedlow, Sanson, Prior, &
Oberklaid, 1993; Roberts & DelVecchio, 2000; Rothbart, Ahadi, & Evans, 2000), this stability is
genetically mediated (e.g., Spengler, Gottschling, Spinath, 2012), and associations between NErelated constructs and psychopathology begin early in development. Dispositional measures of
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negative emotions, such as tendencies toward sadness, anger, irritability, and frustration, have
been associated with internalizing and externalizing problems in young children (Eisenberg et
al., 2001), preadolescents (Anthony & Lonigan, 2002; Oldehinkel, Hartman, Winter, Veenstra, &
Johan, 2004), and adolescents (Silk, Steinberg, & Morris, 2003). Measures of negative emotions
early in childhood prospectively predict higher levels of psychopathology in late adolescence
(Block, Gjerde, & Block, 1991) and young adulthood (Caspi, Moffitt, Newman, & Silva, 1996),
and negative emotionality in late adolescence predicts subsequent development of major
depression in adulthood (Wilson, DiRago, & Iacono, 2013). In one study, examiners rated
children’s behavior at age 3 in an unselected Dunedin birth cohort sample. Factor and cluster
analyses of these ratings revealed five behaviorally and emotionally distinct groups of children
that differed in psychiatric diagnoses at age 21. Behaviorally inhibited children were most likely
to grow up to have depression diagnoses, and behaviorally undercontrolled children were most
likely to have diagnoses of alcohol dependence and ASPD. Both of these groups were
characterized by high negative emotions, including fear and stranger distress for the inhibited
group and irritability and emotionally liability for the undercontrolled group. Importantly, the
three groups with low levels of psychiatric problems at age 21 did not have high levels of
negative emotions, including a reserved group of children who were behaviorally comparable to
the inhibited group but were not described as having fear and distress (Caspi et al., 1996). These
findings highlight the role of NE in early developmental pathways leading to psychopathology
and also suggest a mediating role of inadequate strategies for regulating and processing negative
emotions.
The common liabilities model proposes that the general NE liability influences risk for
INT and EXT disorders both directly by predisposing individuals to experience and express
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negative emotions and indirectly through interactions with genes for lower order genetic
liabilities specific to the INT and EXT factors, in particular liabilities related to the regulation of
behavior, emotion, and thoughts. Regulation difficulties for individuals with EXT disorders lead
them to express the NE liability as dysregulated external behaviors (e.g., aggression toward
others, illicit substance use), whereas regulation difficulties for individuals with INT disorders
lead them to experience the NE liability as internal dysregulation (e.g., rumination, excessive
attention to negative information, persistent distress). In this way, the NE factor increases the
likelihood that INT or EXT factor-specific genes will be expressed as INT or EXT disorders,
thus contributing to the comorbidity of disorders falling into the INT or EXT spectra.
2.2 Regulation Liabilities
In the common liabilities model, the genetic liability for NE—the propensity to
experience negative emotions—typically interacts with genetic liabilities underlying three types
of emotion regulation difficulties to predict psychopathology. More specifically, the shared NE
liability interacts with a liability to behavioral disinhibition (BD), which predisposes individuals
to have difficulty regulating their behavioral responses to negative emotions and increases risk
for externalizing disorders; and liabilities to negative thinking (NT) and physiological
hyperarousal (PH), which predispose individuals to have difficulty internally regulating and
processing negative emotions and increases risk for internalizing disorders. Theory and research
from the developmental literature support this idea that internalizing and externalizing symptoms
stem from a combination of propensities to experience negative emotions and propensities
toward inadequate control of these emotions. Various models of child temperament propose both
reactive traits (e.g., automatic behaviors and unregulated fear) and effortful or active traits (e.g.,
self-regulation abilities and purposeful attentional focus) as components of developmental paths
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leading to psychopathology (Derryberry & Rothbart, 1988; 1997; Kochanska, Barry, Jimenez,
Hollatz, & Woodard, 2009; Lonigan et al., 2004; Muris & Ollendick, 2005; Rothbart, 1989;
Rothbart, Ahadi, & Hershey, 1994; Rothbart, Posner, & Hershey, 1995). A study involving a
Dutch population-based sample of adolescents found that predispositions toward low effortful
control (i.e., tendencies to voluntarily inhibit a dominant response in order to perform a
subdominant but more adaptive response) magnified the effect of fearfulness on internalizing
problems and the effect of frustration on externalizing problems in adolescents (Oldehinkel,
Hartman, Ferdinand, Verhulst, & Ormel, 2007), and effortful control and negative affect were
associated with familial loadings for both internalizing and externalizing psychopathology
(Ormel et al., 2005). In the next two sections, we describe the regulation liabilities in greater
detail from a developmental perspective.
2.2.1 Behavioral Disinhibition Liability for Externalizing Disorders
The EXT latent factor has been associated with low constraint in Tellegen’s (1982)
personality model (Krueger, McGue, & Iacono, 2001), indicating that individuals high in EXT
tend to be impulsive and thrill-seeking and have low adherence to traditional moral values. The
common liabilities model proposes that the high comorbidity among externalizing disorders is
due to a common genetic liability for traits, behaviors, disorders, and endophenotypes that reflect
a propensity toward behavioral disinhibition (BD), such as inattention, aggressiveness,
impulsivity, and low persistence (for a complete review see Iacono, Malone, & McGue, 2008).
Twin and adoption studies support shared genetic influences underlying the traits and
disorders in the EXT spectrum. Multivariate studies indicate shared genetic influences
underlying dependence on various licit substances (Agrawal et al., 2007; Lynskey et al., 2007;
Swan, Carmelli, & Cardon, 1996; True, Xian et al., 1999), common genetic influences on
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different drugs in the illicit substance classes (Agrawal, Neale, Prescott, & Kendler, 2004a;
Karkowski, Prescott, & Kendler, 2000; Kendler, Aggen, Tambs, & Reichborn-Kjennerud, 2006;
Kendler, Jacobson, Prescott, & Neale, 2003; Tsuang et al., 1998), and either shared genetic
influences on dependence across licit and illicit substances (Agrawal & Lynskey, 2006; Hopfer,
Crowley, & Hewitt, 2003; True, Heath et al., 1999) or highly correlated genetic influences on
licit and illicit factors (r = .82; Kendler, Myers, & Prescott, 2007). Other studies support
significant genetic covariation between SUDs and disruptive behavior disorders in childhood
(Burt, Krueger, McGue, & Iacono, 2001; Button et al., 2006; Button et al., 2007; Dick, Viken,
Kaprio, Pulkkinen, & Rose, 2005; Nadder, Rutter, Silberg, Maes, & Eaves, 2002; Silberg et al.,
1996) and between SUDs and adult antisocial behavior disorders (Hicks, Foster, Iacono, &
McGue, 2013; Hicks, Krueger, Iacono, McGue, & Patrick, 2004). Moreover, latent EXT factors
comprised of SUDs and antisocial disorders are highly heritable (Hicks et al., 2007; Hicks,
Schalet, Malone, Iacono, & McGue, 2011; Kendler, Prescott et al., 2003). Finally, research
supports shared genetic risks underlying EXT disorders and other behavioral disinhibition
attributes, such as the personality traits of novelty seeking (Khan et al., 2005) and behavioral
undercontrol (Krueger et al., 2001; Slutske et al., 2002), and early adolescent problem behaviors
like substance experimentation and use, sexual intercourse, and police contact (Keyes, Iacono, &
McGue, 2007; McGue, Iacono, & Krueger, 2006; Young, Stallings, Corley, Krauter, & Hewitt,
2000).
Research on biologically based endophenotypes provides further support for a common
EXT genetic liability. Reduced amplitude of the P300 wave, a nonspecific index of brain
activity, is a well-studied endophenotype that has been associated with childhood disruptive
behavior disorders and antisocial personality disorder (Iacono, Carlson, Malone, & McGue,
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2002), substance misuse and SUDs (Carlson, McLarnon, & Iacono, 2007; Iacono et al., 2002;
Yoon et al., 2006), and the externalizing latent trait (Patrick, 2006). Although the biological
systems underlying individual differences in the P300 wave (Burwell, Malone, Bernat, &
Iacono, 2014) are not well understood, individual differences in P300 amplitude predict
subsequent development of EXT disorders (Iacono et al., 2002; Perlman, Markin, & Iacono,
2013), are heritable (van Beijsterveldt & van Baal 2002; Perlman, Johnson, & Iacono, 2009; van
Beijsterveldt & van Baal, 2002; Yoon et al., 2006), and the association between attenuated P300
amplitude and externalizing disorders is genetically mediated (Hicks et al., 2007a).
The midbrain dopamine reward system is a neurobiological mechanism involved in
addiction to virtually all drugs of abuse (Kosten, George, & Kleber, 2005; Nestler, 2005) that has
been proposed to underlie aggressive behavior as well (Patrick, 2006), which provides further
support for genetic liability shared among SUDs and antisocial disorders. Consistent with this,
Gray’s model of motivational systems proposes two neurologically based personality systems:
(a) the behavioral activation system (BAS), which is exhibited as sensitivity to rewards and
motivation to engage in goal-directed efforts to experience positive feelings; and (b) the
behavioral inhibition system (BIS), which refers to sensitivity to punishments and proneness to
inhibit behavior that may lead to negative or painful outcomes (Gray, 1972; 1975; 1981). EXT
disorders likely reflect increased BAS activation, in the form of midbrain reward system, and
decreased BIS activation (Iacono et al., 2008), which is likely related to diminished prefrontal
cortex functioning and difficulty regulating behavior and inhibiting inappropriate responses
(Bechara, 2005; Miller & Cohen, 2001). BIS and BAS impairment across EXT disorders
underlies high comorbidity among EXT disorders, whereass cross-disorder differences in
BIS/BAS impairment is related to different outcomes among individuals with the BD liability.
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Individuals with SUDs tend to have more BAS problems, individuals with antisocial disorders
tend to have more BIS problems, and individuals with comorbid SUDs and antisocial disorders
tend to have problems with both systems.
Consideration of developmental research is again key to understanding how this genetic
liability contributes to comorbidity. The BD liability is expressed as different phenotypes over
the course of development with the same early temperament traits predicting various subsequent
EXT disorders. Behavioral disinhibition traits, such as lack of inhibitory control, novelty
seeking, and low harm avoidance, when expressed during early childhood predict subsequent
substance use and misuse during adolescence (Caspi, Henry, McGee, Moffitt, & Silva, 1995;
Caspi et al., 1996; Masse & Tremblay, 1997; Wong et al., 2006), and the same traits assessed
during late childhood, adolescence, and young adulthood predict tobacco, alcohol, and illicit
drug symptoms and disorders in later in adulthood (Chassin, Fora, & King, 2004; Cloninger,
Sigvardsson, & Bohman, 1988; Elkins et al., 2006; Grekin, Sher, & Wood, 2006; Krueger,
1999a; Sher, Bartholow, & Wood, 2000). These traits also manifest as disruptive behavior
disorders (e.g., Oppositional Defiant Disorder, CD) during childhood (Young, et al., 2009),
which are predictive of later SUDs (Kim-Cohen et al., 2003; Weinberg, Rahdert, Colliver, &
Glantz, 1998), and as high-risk behaviors during early adolescence, such as antisocial behavior,
experimentation with alcohol, precocious sexual activity, and academic difficulty, which in turn
predict later SUDs and ASPD (Grant & Dawson, 1997; McGue & Iacono, 2005).
These early universal EXT traits become more differentiated across development. Caspi
et al. (1995) found one latent factor for lack of control at ages 3 and 5 that became 2 distinct
factors (an impulsive/undercontrolled factor and a fleeting attention/lack of persistence factor) by
ages 7 and 9 (Caspi et al., 1995). Likewise, a longitudinal study investigating change in the
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underlying structure of the EXT factor from age 17 to 24 found a decrease in the amount of
overlapping variance among externalizing disorders with age (Hicks et al., 2007), reflecting
decreased genetic influence on the covariation among disorders (Vrieze, Hicks, Iacono, &
McGue, 2012). In addition, greater differentiation with age may be due to varied environmental
risk exposure and age-related expression of genes that are specific to certain externalizing
attributes (Agrawal, Neale, Prescott, & Kendler, 2004b; Grant et al., 2006; Hicks et al., 2004;
Kendler, Prescott et al., 2003; Krueger et al., 2002; McGue et al., 2006; Young et al., 2000).
These disorder-specific effects account for relative differences in the extent to which the shared
liabilities contribute to the development of specific disorders and explain why only some and not
other externalizing disorders appear in a given individual with the BD liability. For example,
individuals with extreme antisocial tendencies are likely to be high in BD and relatively low in
NE (Patrick, 2006).
2.2.2 Liability for Internalizing Disorders
Genetic risk factors associated with NE contribute substantially to the genetic overlap
among internalizing disorders (Bienvenu, Hettema, Neale, Prescott, & Kendler, 2007; Fanous,
Gardner, Prescott, Cancro, & Kendler, 2002; Fanous, Neale, Aggen, & Kendler, 2007; Gillespie
& Martin, 2006; Hansell, et al., 2012; Hettema, Neale et al., 2006; Hettema, Prescott, & Kendler,
2004; Kendler & Gardner, 2011; Levinson, 2006). Therefore, we do not propose a specific
liability for the INT factor but rather propose that the NE liability has a strong genetic influence
on the internalizing factor and underlies all depressive and anxiety disorders. Consistent with the
multivariate twin studies, we posit two subfactor-specific genetic liabilities. A liability to
physiological hyperarousal (PH) underlies the disorders in the fear/arousal subfactor (i.e.,
agoraphobia, social phobia, specific phobia, and PD) and is expressed as
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psychophysiological/somatic signs, fear, heightened attention to threats, and behavioral
inhibition. A liability to negative thought processes (NT), including worry, rumination, and
negatively biased attention and interpretation, underlies disorders in the anhdeonia/misery
subfactor (i.e., MDD, persistent depressive disorder, GAD, and PD) and is expressed as habitual
negative attributions and expectations and low positive affect.
This structure for a general NE liability and subfactor-specific PH and NT liabilities is
similar to the tripartite model (Clark & Watson, 1991) and the integrative hierarchical model
(Mineka, Watson, & Clark, 1998). The tripartite model proposes a general distress/negative
affectivity dimension that is common to both depression and anxiety disorders as well as an
anhedonia (low positive affect) factor specific to depression and a physiological hyperarousal
factor specific to anxiety. Our integrative hierarchical model combines elements of the tripartite
model and Barlow’s hierarchical organization of the anxiety disorders (Barlow, 1991; Zinbarg &
Barlow, 1996) and posits that each anxiety and depressive disorder contains both a common
component and a unique component. These models propose a general negative affectivity factor
that accounts for a large proportion of variance in MDD and GAD and a much smaller
proportion of the variance in most other anxiety disorders (e.g., social phobia, specific phobia)
and that negative affectivity and low positive affectivity characterize many noninternalizing
disorders. Watson (2005) further proposed a quantitative hierarchical model in which a general
emotion disorders category can be subdivided into the bipolar disorders (bipolar I, bipolar II,
cyclothymia), the distress disorders (MDD, dysthymic disorder, GAD, and PTSD), and the fear
disorders (panic disorder, agoraphobia, social phobia, and specific phobia; Watson, 2005).
Analogous to the developmental progression of the BD liability, behavioral inhibition,
specifically when it is characterized by poor autonomic regulation (Marshall & Stevenson-Hinde,
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1998), typically appears during early childhood in individuals who will later develop anxiety
(Hirshfeld-Becker et al., 2007; McDermott, et al., 2009), and anxiety may be an earlier
expression of the common NE liability than depression. Anxiety is more likely than depression
to onset during childhood, depression in child and adolescent samples is most often comorbid
with anxiety (Anderson, Williams, McGee, & Silva, 1987; Angold, Costello, & Erkanli, 1999;
Fleming, Offord, & Boyle, 1989), and the onset of anxiety tends to precede the onset of
depression (Hettema, Kuhn et al., 2006; Kessler et al., 2005; Woodward & Fergusson, 2001).
Twin studies of children and adolescents support significant genetic covariation between anxiety
and subsequent depression that cannot be explained by genetic influences associated with earlier
depression (Eaves et al., 2003; Rice et al., 2004), suggesting shared genetic etiology of childhood
anxiety and later depression. Anxiety and depression do not always co-occur and anxiety does
not always precede depression, but these findings support a common liability underlying the two
separate INT subfactors.
Research on associations between temperament/personality traits and depressive and
anxiety disorders supports the PH and NT liabilities. Many concurrent and a few prospective
studies of children and adolescents have consistently found associations between high negative
affect/neuroticism and both depression and anxiety, low positive affect/surgency and depression,
and high physiological arousal and anxiety (e.g., Caspi et al., 1996; Chorpita & Daleiden, 2002;
Compas, Conner-Smith, & Jaser, 2004; Lonigan, Carey, & Finch, 1994). Studies involving adult
samples have similar findings. Internalizing factors defined by both depression and anxiety
symptoms tend to have smaller correlations with positive emotionality than with negative
emotionality (Krueger et al., 2001). Krueger (1999b) found a significant negative association
between depressive disorders and the well-being dimension of Tellegen’s Multidimensional
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Personality Questionnaire (which is described as cheerfulness, optimism, and proneness to
enjoyment) and no association between well-being and anxiety disorders (Krueger, 1999a). In a
similar way, constraint, a personality factor defined as a propensity for cautious and restrained
behavior and endorsement of traditional values, does not typically correlate with the general INT
factor (Krueger et al., 2001), and high constraint is characteristic of individuals with anxiety
disorders but not depressive disorders (Krueger, 1999a). Consistent with the specificity of
constraint to the PH liability, Gladstone et al. (2006) found that social anxiety mediated the
relationship between childhood inhibition and later depression (Gladstone, Parker, Gladstone, &
Parker, 2006).
2.2.2.1 Physiological Hyperarousal Liability. Some anxiety is normative, particularly in
infancy and toddlerhood in response to separation from parents. This fear typically diminishes
dramatically during early childhood (Muris, Meesters, Merckelbach, Sermon, & Zwakhalen,
1998), an age when fear-based anxiety disorders, such as separation anxiety disorder, social
phobia, and specific phobias, are likely to onset (Kessler et al., 2005). Fear in these young
children has significant genetic overlap with shyness/inhibition (62%) and negative mood (53%;
Eley et al., 2003), suggesting developmental continuity with later internalizing disorders that
share these traits, particularly disorders in the FA subfactor. These disorders are characterized by
behavioral constraint (Krueger, 1999a) and intense physiological hyperarousal (PH), such as
heart racing, sweating, and shortness of breath particularly in response to stressors (Cuthbert et
al., 2003; Hofmann, Moscovitch, & Kim, 2006; Martin-Soelch, Stocklin, Dammann, Opwis, &
Seifritz, 2006).
Turning to evidence of potential endophenotypes, research on psychophysiological
characteristics of anxious and depressed individuals supports the distinction of the PH and NT
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liabilities within internalizing psychopathology. Anxiety disorders loading on the FA factor are
characterized by poor parasympathetic flexibility (Licht, de Geus, van Dyck, & Penninx, 2009;
Sharma, Balhara, Sagar, Deepak, & Mehta, 2011) and exaggerated sympathetic arousal to
affectively arousing stimuli, especially fear stimuli (Cuthbert et al., 2003; Larson, Nitschke, &
Davidson, 2007). Cuthbert et al. (2003) found that individuals with PD were less physiologically
responsive to the affective stimuli than individuals with specific phobias and social anxiety, a
finding that is consistent with PD’s relatively smaller genetic loading on the FA factor (Kendler,
Prescott et al., 2003). Moreover, depressed individuals without anxiety disorders and anxious
individuals with worry or anhedonic symptoms but not arousal symptoms do not show
exaggerated physiological responses to these stimuli (Larson et al., 2007), and researchers have
found blunted physiological responses to pleasant stimuli among individuals with depression
(Forbes, Miller, Cohn, Fox, & Kovacs, 2005; Larson et al., 2007). A comprehensive review of
this literature supports these conclusions (Vaidyanathan, Patrick, & Cuthbert, 2009) and links the
differentiation of INT disorders to distinct underlying brain systems. Few studies have
investigated the heritability of these psychophysiological indices. The extant literature supports
modest genetic influences on conditioned eyeblink responses (Merrill, Steinmetz, Viken, &
Rose, 1999) and on absolute startle reflex but not emotion-modulated startle reflex (Anokhin,
Golosheykin, & Heath, 2007; see also Carlson, Katsanis, Iacono, & McGue, 1997). Research on
the heritability of these psychophysiological indices is needed to establish their potential as
endophenotypes for FA-INT disorders.
The amygdala is the primary brain structure for processing fear, and it has been linked to
behavioral inhibition (Haas, Canli, Haas, & Canli, 2008; Kensinger & Corkin, 2004; Morgan &
Morgan, 2006), suggesting neural substrates implicated in the functioning of the amygdala are
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also potential endophenotypes for FA-INT disorders and their precursors. Pharmacological
studies indicate that blockage of receptors in the amygdala (e.g., N-methyl-D-aspartate, NMDA,
receptors) inhibits fear responses and consolidation of fear memories, and NMDA antagonists
successfully treat various anxiety disorders (Garakani, Mathew, & Charney, 2006). Impairment
in amygdala functioning is also implicated in nonfear disorders (e.g., MDD), but genes
associated with functioning of the amygdala receptors and neurotransmitters that bind to these
receptors likely contribute considerably to the PH liability. Research showing associations
between anxiety disorders and measures of heart rate variability and respiratory sinus arrhythmia
in response to emotion-laden stimuli (e.g. Licht et al., 2009; Porges, 2011) suggest the
physiological substrates underlying parasympathetic functioning may also be key
endophenotypes.
2.2.2.2 Negative Thought Processes Liability. Twin studies have demonstrated substantial
genetic covariance between MDD and GAD, and a significant proportion of that genetic overlap
is due to the common genetic liability for NE (Hettema, Neale et al., 2006; Kendler, Gardner,
Gatz, & Pedersen, 2007; Middeldorp, Cath, Van Dyck, & Boomsma, 2005). Nevertheless,
Hettema et al. (2006) found a significant genetic factor shared among MDD, GAD, and PD that
was independent from the genetic influences of neuroticism, and Kendler et al. (2007) found that
only about 25% of the genetic correlation between MDD and GAD was shared with neuroticism,
leaving a considerable amount of shared genetic variation to be explained by other factors. We
propose that the comorbidity among the disorders in the INT-AM subfactor are explained by a
genetic predisposition for various interrelated negative thought (NT) processes that have
empirical links to depression and anxiety, including attentional biases to threatening and sad
stimuli, excessive contemplation of negative information, difficulty shifting attention away from
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negative information, and trouble suppressing pessimistic cognitions (e.g., Bradley, Mogg,
White, Groom, & de Bono, 1999; Everaert, Koster, & Derakshan, 2012; Gotlib & Joormann,
2010; Hirsch, Clark, & Mathews, 2006; Mathews & MacLeod, 2005; Mogg, Philippot, &
Bradley, 2004; Vanderhasselt, et al., 2012; Zetsche, D'Avanzato, & Joormann, 2012). This
predisposition underlies cognitive characteristics of these disorders, like worry, rumination,
hopelessness, and negative attributions about the self and the future (e.g., Alloy et al., 2004;
Nolen-Hoeksema, Wisco, & Lyubomirsky, 2008; Papageorgiou, 2006), as well as anhedonia and
low levels of positive affect which are also characteristics of these disorders (Krueger, 1999a;
Watson, 2005). Individuals with an INT-AM disorder inherit both the NE liability and the NT
liability and thus are prone to high levels of fear, anger, and sadness and to maladaptive
cognitive processing and internal regulation of these negative emotions.
This cognitively based NT liability is consistent with the many cognitive theories of
depression and anxiety, such as Beck’s cognitive distortion model (Beck, 1967; 1976), the
learned helplessness and hopelessness models (Abramson, Metalsky, & Alloy, 1989; Abramson,
Seligman, & Teasdale, 1978; Seligman, 1974), Eysenck’s hypervigilance theory of anxiety
(Eysenck, 1992; 1997), and Beck’s information processing model of anxiety (Beck & Clark,
1997). Furthermore, the combination of NE and NT liabilities is supported by transdiagnostic
emotion regulation models that propose maladaptive cognitive regulation of negative emotions
contribute to depression and anxiety (Aldao & Nolen-Hoeksema, 2010; Gross & Thompson,
2007; Hofmann, Sawyer, Fang, & Asnaani, 2012) and findings that cognitive processes, such as
attentional biases toward threatening stimuli, moderate associations between behavioral
inhibition and internalizing problems (e.g., Fox & Pine, 2012; Pérez-Edgar et al., 2011).
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Although few studies have investigated the heritability of the many cognitive constructs
associated with depression and anxiety, the few existing studies generally support moderate
genetic influences on these constructs. Attributional style, a cognitive pattern characterized by
internal, global, and stable attributions for negative events, was found to be moderately heritable
(35%; Lau, Rijsdijk, & Eley, 2006) in a sample of adolescents, and anxiety sensitivity, which
refers to beliefs about the harmful consequences of anxiety, was also moderately heritable in
samples of adolescents (60%; Eley & Brown, 2004) and adults (45%; Stein, Jang, & Livesley,
1999). Eley and colleagues studied genetic influences on various simple cognitive variables in 8year-old children. They found significant genetic influences on anxiety sensitivity (37%; Eley,
Gregory, Clark, & Ehlers, 2007) but negligible genetic influences and significant shared
environmental on negative interpretations of interpersonal relationships (Gregory et al., 2007).
Genetic influences on anxiety sensitivity were highly correlated with genetic influences on
panic/somatic symptoms of anxiety in children (Eley et al., 2007), and genetic influences on a
measure of children’s interpretations of situations as either negative or neutral were significantly
correlated (r =.65) with genetic influences on children’s depressive symptoms (Eley et al., 2008).
Like the BD and PH liabilities, the NT liability should be conceptualized in a
developmental context as behavioral tendencies, temperament traits, and physiological processes
begin to emerge in childhood and predispose individuals to develop INT-AM disorders.
Although the ability to internally regulate emotions emerges in the first year of life (e.g., selfsoothing), self-regulation abilities continue to develop rapidly through the critical preschool
years and into childhood and adolescence (Cole, Michel, & Teti, 1994; Gralinski & Kopp, 1993;
Kaler & Kopp, 1990; Rothbart, Posner, & Rosicky, 1994). Young children, who lack the
cognitive abilities to develop stable expectancies and explanations for stress and negative
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emotions, express maladaptive internal regulation as behavioral restraint, shyness, and low
attention regulation (Cicchetti & Tucker, 1994; Eisenberg et al., 2001; Nolen-Hoeksema, Girgus,
& Seligman, 1992; Turner & Cole, 1994). Improved cognitive abilities during late childhood and
adolescence allow for the development of more stable and pathological cognitive styles, such as
pessimistic beliefs about causes and consequences of stressful events and hopelessness about the
future (Kaslow, Adamson, & Collins, 2000; Nolen-Hoeksema et al., 1992). By early
adolescence, rumination, poor ability to shift attention away from aversive or negative stimuli
when desired, high self-criticism, dysfunctional interpretation schemas, hopelessness about the
future, and negative views of self, world, and future are associated with higher levels of
internalizing problems (Bachanas & Kaslow, 2001; Murisa, Meesters, & Blijlevens, 2007;
Oldehinkel et al., 2004; Silk et al., 2003).
With respect to endophenotypes, studies linking depression and anxiety to genes related
to serotonergic modulation of the stress response (e.g., serotonin transporter gene; Holmes, 2008;
Koller et al., 2008) and genes linked to HPA axis regulation (e.g., glucocorticoid receptor gene;
Brouwer et al., 2006; Papiol et al., 2007) suggest that biological markers of HPA axis and
serotonergic system functioning may be promising INT-AM disorder endophenotypes. Complex
interactions between genetic susceptibility to serotonergic and noradrenergic system dysfunction
and stress-related changes in the HPA axis have been implicated in the etiology of depression
(Firk, Markus, Firk, & Markus, 2007; Porter et al., 2004), and psychopharmacological treatment
studies support the role of reduced neurotransmission of serotonin and norepinephrine in the
pathophysiology of GAD (Nutt, Argyropoulos, Hood, & Potokar, 2006). Despite the extensive
body of research linking corticotrophin-releasing factor and the HPA axis to depression (Hankin,
Badanes, Abela, & Watamura, 2010; Nemeroff & Vale, 2005; Wardenaar, et al., 2011), almost
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no research has investigated the role of the HPA axis in the etiology of GAD separate from the
INT-FA anxiety disorders. Although findings of associations between the HPA axis functioning
and anxiety disorders in general have been mixed (Risbrough & Stein, 2006), evidence from a
study of HPA functioning in GAD patients showed significant changes in plasma cortisol
following cognitive treatment (Tafet, Feder, Abulafia, & Roffman, 2005).
2.3 Molecular Genetics: Identifying Genes
At present, the specific genes associated with the NE, BD, PH, and NT liabilities are
unknown, and thus we limit our discussion of candidate genes to a few brief comments.
Interpreting research on candidate genes for psychiatric disorders and personality traits is
complicated because effects are likely due to multiple genes, each of which has small effects.
Very large samples, replication across samples, and strong biologically informed a priori
hypotheses are needed to place candidate gene findings on solid footings, and even then there is
reason to be cautious regarding the likelihood that reported effects are not false-positive errors,
especially when testing for gene x environment interactions (Duncan & Keller, 2011).
Nevertheless, promising leads are being developed, and findings from molecular genetic studies
support common genetic liabilities. Studies support over-transmission of the risk variants of
various genes in individuals with different psychiatric disorders. For example, the muscarinic
acetylcholine receptor M2 gene (CHRM2) is involved in the stress response system among other
functions (e.g., attention, learning, memory and cognition) and has been linked to alcohol and
drug dependence (Wang et al., 2004), a general composite externalizing factor (Dick et al.,
2008), and depression (Comings et al., 2002). In addition, findings regarding genes involved in
SUDs (e.g., related to dopamine functioning) have also been implicated in BD traits like
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impulsivity and risk taking (Hiroi & Agatsuma, 2005; Kreek, Nielsen, Butelman, & LaForge,
2005) and the association between neuroticism and SUDs (Ellis et al., 2011).
3. Environmental Mediation and Moderation of Genetic Liabilities
Environmental factors are also important to the etiology of mental disorders and thus may
contribute to comorbidity. In the common liabilities model, environmental risks are depicted as
coalescing under a general factor that is influenced by the genetic liabilities and influences both
INT and EXT psychopathology. By and large, environmental risks overlap extensively across
disorders and EXT/INT factor groups. For example, low family support, conflict with peers, peer
pressure, and broken relationships are associated with risk for substance use and depression in a
sample of adolescents (e.g., Aseltine, Gore, & Colten, 1998). Nevertheless, some environmental
risk factors are likely to influence certain disorders to a greater degree than other disorders, and
thus contribute to disorder specific effects, for example, peer pressure may be a stronger
predictor of substance use and conflict with friends may be a stronger predictor of depression
(Aseltine et al., 1998). Consistent with largely shared but some specific environmental effects,
findings from a multivariate twin study suggest that factor-specific environmental risks do not
distinguish INT disorders from EXT disorders, although some environmental influences are
likely specific to smaller subsets of disorders, such as CD and ASPD and MDD, GAD, and
alcohol dependence (Kendler, Prescott et al., 2003).
The influence of environmental risk mechanisms on comorbidity is due in part to the
tendency for multiple environmental risks to co-occur. For example, exposure to interparental
conflict in the home is related to conflict with peers and peer rejection (Hipwell, Murray,
Ducournau, & Stein, 2005; Kunz, 2001), and exposure to criminal and violent acts, deviant
peers, and drug accessibility (all risk factors for both substance use and depression) tend to co-

26

occur in the same neighborhoods (Curry et al., 2008; Stockdale et al., 2007; Valdez, Kaplan, &
Curtis, 2007). “Environmental” risk factors, such as family conflict and affiliation with deviant
peers, have been found to be genetically influenced (McGue, Elkins, Walden, & Iacono, 2005;
Plomin & Bergeman, 1991; Tarantino et al., 2014), and thus genetic factors may also contribute
the co-occurrence of multiple environment risks.
Research supports the “cumulative risk hypothesis” that added exposures to multiple
risks across different stages of development convey greater risk than single exposure or exposure
in a single developmental period. This repeated exposure to environmental risks also amplifies
gene expression through gene-environment (G-E) interplay (Rutter & Silberg, 2002), which
contributes to increased heritability of most mental disorders with age (Bergen et al., 2007).
Gene-environment correlation is one mechanism of G-E interplay that contributes to comorbidity
(Jaffee & Price, 2007). Genetic and environmental risks are correlated because parents transmit
risk to offspring both by passing on genes to their offspring and by shaping their offspring’s
environment (contributing to “passive” G-E correlations) and because genetically influenced
behavior directly influences the environment (contributing to “active” G-E correlations). For
example, genetic liability to BD increases risk for both EXT disorders and exposure to
environmental factors like parental conflict and affiliation with defiant peers (Keyes et al., 2007),
which are nonspecific environmental factors that potentiate risk for EXT and INT disorders.
Environmental factors also interact with genetic factors to increase or decrease risk for
disorders. For example, genetic influences on substance use and deviant behaviors are amplified
in urban settings where environmental risks (e.g., easy access to drugs, exposure to violence, and
perhaps less parental monitoring) are more common than in rural environments (Legrand, Keyes,
McGue, Iacono, & Krueger, 2007; Rose, Dick, Viken, & Kaprio, 2001). As follows,
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environmental risks may also contribute to comorbidity by increasing the likelihood that
common and disorder-specific genetic liabilities are expressed as mental disorders. Thus, genes
and the environment influence each other and risk for disorders in a complex, reciprocal ways,
and, importantly, because neither the genetic nor the environmental risk factors are disorderspecific, these G-E interplay mechanisms contribute to comorbidity of mental disorders.
4. Explaining Co-occurrence of SUDs and Other Disorders
Our common liabilities model explains comorbidity among mental disorders in general.
In this section, we focus on how the model explains comorbidity with SUDs in particular and
highlight some important assumptions of the model. The degree of influence of a given
mechanism on the comorbidity of SUDs with another disorder varies from disorder to disorder.
Likewise, the mechanism underlying the co-occurrence of two disorders in a given individual
varies from person to person. Characteristics of the two disorders, such as age of onset and
temporal order of emergence of the disorders, provide insight about the mechanisms underlying
comorbidity.
4.1 Behavioral Disinhibition Liability: Link between SUDs and Antisocial Disorders
The model proposes that the BD genetic liability is the most likely factor underlying the
comorbidity of SUDs with antisocial behavior disorders, and that when SUDs are comoribid with
antisocial disorders the age of initiation of substance use is typically during early adolescence.
As we have previously discussed, the typical progression of externalizing problems related to the
BD liability is (a) impulsivity, inattention, and aggressiveness during early childhood; (b)
disruptive behavior disorders during childhood; (c) antisocial behaviors, initiation of substance
use, precocious sexual activity, affiliation with deviant peers, and parent-child conflict during
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early to mid-adolescence; and, finally (d) finally the emergence of alcohol and drug
abuse/dependence and ASPD in adulthood (Iacono et al., 2008).
In a review of comorbidity of SUDs in samples of youth, Armstrong and Costello (2002)
report that approximately 60% of youth with an SUD have a comorbid disorder, and early-onset
SUDs are most often comorbid with CD and oppositional defiant disorder (Armstrong &
Costello, 2002). A longitudinal study of childhood internalizing and externalizing disorders and
early adolescent substance use supports this idea. King, et al., (2004) found that disruptive
behavior disorders (CD, ODD, and, to a lesser extent, ADHD) in male and female 11-year-olds
were robust predictors of age 14 substance use behaviors (e.g., use of alcohol, cigarette, and
cannabis one or more times per month and being drunk; King, Iacono, & McGue, 2004). MDD
and anxiety disorders were much less consistently predictive of substance use behaviors at age
14. Thus, through a developmental progression of expressed externalizing traits, behaviors, and
environmental risks, the comorbidity of SUDs with CD and ASPD is most likely influenced
through a general genetic liability to BD.
4.2 General NE liability: Link between Alcohol Use Disorder and Anhedonia/Misery Disorder
In the model, the NE liability has its greatest influence on INT disorders, particularly the
INT-AM disorders, and the model proposes that NE also has a strong effect on alcohol use
disorder (AUD) and contributes to the high comorbidity between alcoholism and depression.
Several lines of research support this idea. First, although alcohol dependence has a stronger
loading on the EXT factor than the INT factor, there is evidence from twin studies that
nevertheless suggests some shared latent covariance between alcohol dependence and the INT
factor (Kendler, Prescott et al., 2003; King et al., 2004; Krueger et al., 2001). Second, twin
studies have demonstrated that genetic factors underlie the comorbidity of depression and
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alcohol dependence (Kendler, et al., 1993; Prescott, Aggen, & Kendler, 2000). Third, although
high negative emotionality has been associated with substance dependence in general (Krueger,
1999a), it appears to have an especially strong association with AUD. McGue and colleagues
(1997; 1999) found that alcohol dependence is particularly common among individuals who have
high levels of both behavioral disinhibition and negative emotionality and that alcohol
dependence is primarily associated with negative emotionality, while illicit drug use disorders
are primarily associated with constraint (McGue, Slutske, & Iacono, 1999; McGue, Slutske,
Taylor, & Iacono, 1997). Similarly, Elkins et al. (2004) found that adolescent offspring of
parents with a history of alcohol dependence scored significantly higher on negative emotionality
than adolescents with no parental history of alcohol dependence, and negative emotionality did
not differ for offspring of parents with and without a drug abuse/dependence history (Elkins,
McGue, Malone, & Iacono, 2004). They found that this pattern characterized both offspring with
an SUD and those who had not yet developed an SUD, which supports negative emotionality as
an indicator of familial risk for alcoholism.
Fourth, research suggests that understanding how the NE liability mechanism contributes
to the comorbidity of SUDs and internalizing disorders requires studying specific negative
emotions (e.g., Lara, Pinto, Akiskal, & Akiskal, 2006). Findings suggest that irritability and
anger are associated with both alcohol use and depression but not with anxiety
(Fava, et al., 2010; Hussong & Chassin, 1994; Lara et al., 2006; Pardini et al., 2004; Tarter,
Blacksona, Brighama, Mossa, & Caprarab, 1995). These findings suggest that NE-related
proneness toward irritability and anger may underlie the comorbidity of alcohol dependence and
internalizing disorders within the INT-AM factor specifically. The proneness toward irritability
and anger is likely influenced by disorder-specific genetic and environmental factors and perhaps
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by the environmental factors that Kendler et al. (2003) found were shared among MDD, GAD,
and alcohol dependence. The factors underlying the comorbidity of alcohol dependence with
INT-FA disorders would likely be different and perhaps involve specific effects that remain to be
identified.
4.3 Environmental Mechanisms
Environmental factors likely contribute to the comorbidity of SUDs with both INT and
EXT disorders through shared environmental risk factors, the tendency for multiple
environmental risks to co-occur, and G-E interplay. We expect, though, that environmental risk
factors are relatively more influential than genetic factors when the comorbid SUD has a late
onset and the relative influence of environmental factors to genetic factors is greater for the
comorbidity between SUDs and INT disorders than SUDs and EXT disorders. Because the BD
liability is likely to be expressed as substance use relatively early in adulthood or even in
adolescence, it is less likely that the SUDs with a late age of onset are strongly influenced by this
genetic liability. Although the NE liability contributes to comorbidity between INT disorders and
SUDs, research also suggests that stress, particularly chronic stress over time, and the
neurobiological effects of chronic stress response systems (e.g., on HPA system functioning)
plays an important role in the comorbidity of internalizing disorders and SUDs (Brady & Sinha,
2005).
4.4 Other Explanations for Comorbidity
Other explanations for the comorbidity of SUDs with other disorders are also supported
by research. One commonly posited explanation is directional or reciprocal causality in which
one disorder or the consequences of the disorder (e.g., neuroadaptations associated with chronic
drug use) cause a second disorder, and these causal links may be reciprocal. Several lines of
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research support this explanation. First, internalizing (e.g., MDD, PD) and externalizing
disorders (e.g., CD, ODD) have been found to prospectively predict SUDs and vice versa
(Breslau, Novak, & Kessler, 2004; Fergusson, Boden, & Horwood, 2009; Goodman &
Capitman, 2000; Greenfield et al., 1998; Kushner, Sher, & Erickson, 1999; Marmorstein &
Iacono, 2011; Marmorstein, Iacono, & Malone, in press; Rao et al., 2000). These findings are
consistent with directional causality, but findings of directionality do not necessarily imply
causation and also do not rule out a common liability explanation for comorbidity.
Second, when depressive or anxiety disorders precede SUDs, a common explanation is
the “self-medication” theory, which proposes that individuals begin using substances to “treat”
symptoms of a primary disorder. For example, nicotine dependence co-occurs with depression,
and smoking results in marked reductions in brain levels of monoamine oxidase A (MAO-A;
Fowler et al., 1996), an enzyme that degrades serotonin and norepinephrine. MAO inhibitors are
antidepressant drugs that block this process (Adli et al., 2008), suggesting that smoking, too, may
have an antidepressant effect. The self-medication theory, though, is challenged by findings that
SUDs often precede internalizing disorders (Fergusson, et al., 2009; Marmorstein, et al., 2010;
Rao et al., 2000) and by a study that used biometric modeling to compare etiological models for
the comorbidity of nicotine dependence and depression and found support for a correlated or
shared familial liability (perhaps a common NE liability) rather than for one disorder leading to
the other (Johnson, Rhee, Chase, & Breslau, 2004).
Third, longitudinal studies of adolescent and young adults have found that episodes of
depression and substance use tend to occur in close temporal proximity (Fergusson, et al., 2009;
Rao et al., 2000). This research may indicate bidirectional influence of symptoms of the
comorbid disorders but may also be explained by common environmental triggers, greater use of
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substances when feeling depressed among individuals who have a common genetic liability for
both disorders, or negative consequences of one of the disorders (e.g., failing grades, strained
interpersonal relationships) increasing symptoms of the other disorder. Fourth, when SUDs are
comorbid with another condition, SUD symptoms tend to be more severe (Conway et al., 2006;
Grant et al., 1996), durations of remission and time to relapse are shorter (Greenfield et al., 1998;
Hasin et al., 2002), and treatments are less effective unless there is conjunctive treatment for the
comorbid disorder (Myrick & Brady, 2003). These findings may indicate that the comorbid
disorder exacerbates (or is causally linked to) SUD symptoms, but these findings may also
suggest a common genetic liability that underlies more severe, chronic, treatment-resistant
symptoms of both disorders.
In summary, these lines of research are consistent with directional and reciprocal
causality but are also compatible with a common liabilities model. These two explanations for
comorbidity are not mutually exclusive, and both likely contribute to comorbidity in complex
ways. To be more specific, the presence of a genetic liability does not determine that a disorder
will develop but rather increases the likelihood that a disorder will develop given the presence of
other genetic and environmental risk factors, which may include other psychiatric disorders. For
example, a common genetic liability for NE increases the likelihood of developing both AUD
and social anxiety disorder, and the liability may be expressed first as social anxiety symptoms
which in turn casually contribute to the liability being expressed as alcohol dependence. The
causality explanation is also likely complicated and mediated by changes in environmental risks
(e.g., unemployment, strained interpersonal relationships, unhealthy compensatory strategies
used to manage the primary disorder) and changes in the individual that are probably genetically
influenced to some degree (e.g., changes in brain structures and functions, cognitive processes).
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Both common liabilities and causal relationships between comorbid disorders likely contribute to
the noted strong correlations between the INT and EXT factors and the subfactors and among the
individual disorders. Therefore, the hierarchical common liabilities model is not intended to be
exhaustive or exclusive of other explanations for comorbidity but rather to integrate important
findings about phenotypic covariance, genetics, environmental influences, biological systems,
and developmental changes.
5. Conclusion
5.1 Summary
The etiology of mental disorders is increasingly understood to involve many interacting
genes and environmental factors. Individual pathways of risk begin with general genetic
liabilities that, throughout development, interact with environmental factors and other genetic
factors and result in increased likelihood of developing some mental disorders and decreased
likelihood of developing other disorders. This chapter provided a review of research on
comorbidity with SUDs and proposed an integrative hierarchical model based on phenotypic
covariance and latent genetic liabilities to explain observed patterns of disorder co-occurrence.
The highest order factor, NE, increases risk for all INT and EXT mental disorders included in
Figure 1. In other words, individuals with these mental disorders are likely to share, to varying
degrees, the genetic liability for NE, with any particular disorder they develop shaped by the
presence of other genes (e.g., genes affecting liability for disorders associated with BD) and
environmental factors. The comorbidity of disorders increases as the number of shared genetic
liabilities and shared environmental influences increases. Disorders falling in the same INT/EXT
spectra have high comorbidity because individuals with these disorders are likely to inherit not
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only the NE liability but also a more specific genetic liability that is shared by disorders in the
spectrum.
Further differentiation occurs because each disorder in the model is also influenced by
specific effects that are unique to the disorder and account for the development of different
disorders among individuals who share these higher order liabilities. These specific genetic and
environmental effects differ in nature across the disorders, and the proportion of genetic to
environmental influence unique to a disorder varies from one disorder to another. Using
multivariate twin modeling, Kendler et al. (2003) found that disorder-specific loadings for
unique (i.e., not shared among family members) environmental influences on these common
mental disorders were substantial, whereas environmental influences shared among family
members were very small. The magnitude of disorder-specific genetic loadings varied across
disorders with substantial loadings found only for alcohol dependence and drug
abuse/dependence, suggesting that these specific effects are largely environmental. As follows,
genetic and environmental influences at the higher levels of the hierarchy explain comorbidity
among different disorders and specific genetic and environmental influences at the lowest level
of the hierarchy account for multifinality and the etiology of individual disorders.
5.2 Limitations
Despite the breadth and comprehensiveness of this model, it does not attempt to account
fully for mental disorder co-occurrence or to exclude other mechanisms that may also contribute
to comorbidity (e.g., one disorder causing the other). The model focuses on common disorders
that have typically been assessed in epidemiologic and behavior genetics investigations that
examine the underlying structure of psychopathology and thus are known to have shared
covariance with other INT or EXT disorders. Consequently, some disorders (e.g., posttraumatic
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stress disorder, personality disorders besides ASPD, psychotic disorders, bipolar disorders) are
not included in the model. In addition, the model does not distinguish among different illicit drug
use disorders. Further, relevant moderating variables, such as gender, ethnicity, and family
history of psychopathology, are not included in the model but would improve the specificity of
the model for understanding comorbidity in distinct groups and under various conditions. It is
important to note, though, that although there are well-known gender differences in the mean
level of EXT and INT attributes, many studies find no gender effects pointing to differences in
the etiology of mental disorders, for example, in the hierarchical factor structures of
psychopathology (Krueger, 1999b), the structure of genetic and environmental influences on
externalizing disorders (e.g., Hicks et al., 2007; Kendler, Prescott et al., 2003), heritability of
disorders (Heath et al., 1997; Sullivan et al., 2000), and relationships between personality or
temperament and psychopathology (Oldehinkel et al., 2004).
5.2 Implications and Future Directions
The goal of this chapter was to propose an integrative, research-derived model that
provides an organizational framework for guiding future research on the origins of comorbid
mental disorders. Although the structure and components of the model are all empirically
derived, some components have more empirical support than others. The liability to persistent
negative thinking, for example, is certainly consistent with theoretical models of depression and
anxiety and findings of characteristic negative thinking patterns in depressed and anxious
individuals, but almost no research has investigated the genetic basis of these negative thinking
patterns, the genetic covariation between these thinking patterns and internalizing
psychopathology, or endophenotypes related to these constructs. Better phenotypic
characterization of the behaviors, traits, and cognitive processes associated with these genetically
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influenced liabilities and research on the genetic covariation between these liabilities and
psychopathology will advance our understanding of the structure underlying comorbidity of
mental disorders. These broad phenotypes can then be used in the search for specific genes
associated with psychopathology and, when studied in conjunction with specific disorders, will
ultimately lead to delineation of the etiology and biological processes shared among comorbid
disorders and biological processes that distinguish mental disorders. In addition, research on
endophenotypes for the liabilities is lacking and is important for linking the neurobiological,
genetic, and phenotypic findings to better understand the diverse, complex, interacting systems
that contribute to comorbidity. Studies that use an interdisciplinary approach to investigating the
interplay of genetics, neurobiological systems, and environmental factors will be key to
understanding comorbidity.
This model can also be used to guide research on the genetic and environmental factors
underlying psychopathology more broadly defined. Feinstein (1970), who coined the term
comorbidity, originally described a broad construct that referred to comorbidity not just among
medical disorders but also among symptoms of disorders and other clinical phenomena that do
not meet criteria for disease status (Feinstein, 1970; Krueger & Markon, 2006). Krueger (2002,
2005) and others have provided evidence that psychopathology is best conceptualized along
continuous dimensions, rather than as discrete entities (Krueger, et al., 2005; Krueger &
Piasecki, 2002). In fact, psychopathology researchers have debated use of the term
“comorbidity” to describe mental disorders and how to best conceptualize the observed cooccurrence of mental disorders. Lilienfeld et al. (1994) and others discussed concerns that the
term comorbidity inappropriately reifies psychopathology as defined by discrete, wellunderstood categorical diagnoses with distinct etiologies rather than conceptualizing it in a
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dimensional framework (Lilienfeld, Waldman, & Israel, 1994; Meehl, 2001), while others have
argued that the concept of comorbidity is useful even when categories do not have clearly
distinct etiologies (Spitzer, 1994). Krueger and Markon (2006) raise the related concern that cooccurrence of two legitimate diagnoses in a single individual should be distinguished from
correlation or covariation of diagnoses in a group of people (Krueger & Markon, 2006).
Regardless of whether or not the term “comorbidity” and discrete diagnostic categories are used,
the empirical evidence and the proposed common liability model suggest that advancing our
understanding of the origins of comorbidity (or “co-occurrence") requires broadening our
conceptualization of this phenomenon to include not only diagnoses or dimensional measures of
psychopathology but also related personality traits, behavioral tendencies, and neurobiological
systems. It requires studying these broad factors from a developmental perspective in order to
understand developmental differences in the expression of genetic liabilities, the progression of
risk from early appearances of problems to impairing psychopathology, and how genetic and
environmental interplay affects the course of comorbid disorder development. Finally, it implies
that efforts to find genes for SUDs and related psychopathology would do well to capitalize on
what we know about comorbidity. That is, rather than only trying to find genes for specific
SUDs, efforts directed at finding genes associated with the covariance among disorders are also
needed. Because behavior genetic studies have shown that the latent traits underlying this
covariance are more heritable than the individual characteristics comprising it, gene finding
approaches targeting the latent traits have strong payoff potential.
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Figure Caption
An integrative model that explains comorbidity among substance use disorders and other
common mental disorders through a hierarchical structure of general and disorder-specific
genetic and environmental effects. A broad externalizing factor represents the covariance among
conduct disorder, antisocial personality disorder, tobacco use disorder, drug use disorders, and
alcohol use disorder, and a broad internalizing factor represents the covariance among depressive
and anxiety disorders. The internalizing factor is further divided into two subfactors: (1) an
anhedonia/misery factor that represents the covariance among major depressive disorder,
persistent depressive disorder, and generalized anxiety disorder; and (2) a fear/arousal factor that
represents the covariance among specific phobia, social anxiety disorder, and agoraphobia. Panic
disorder loads onto both internalizing subfactors. These internalizing and externalizing factors
derive from genetically influenced biological predispositions/liabilities, each of which is
expressed as a spectrum of related personality traits, cognitive processes, and behavioral
tendencies. At the highest level of the hierarchy, a liability to negative emotionality (NE;
proneness to experiencing negative emotions, tendency toward dysregulation) influences risk for
both externalizing and internalizing disorders. The NE liability has particularly strong loadings
(bold lines) on the internalizing factor and on alcohol use disorders and thus is a substantial
contributor to comorbidity among internalizing disorders, as well as between internalizing
disorders and alcohol use disorders. Negative emotionality has a smaller effect on comorbidity
between INT disorders and other externalizing disorders. At the next level of the hierarchy, a
liability to behavioral disinhibition (BD; undercontrolled behavior, low levels of persistence,
aggressiveness, impulsivity, inattention) underlies risk for disorders in the externalizing factor. A
liability to negative thought processes (NT processes; low positive affect, habitual negative
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attributions and expectations, biased attention and memory, worry, rumination) contributes to
risk for the anhedonia/misery disorders. A liability to physiological arousal (PH;
psychophysiological/somatic signs, fear, heightened attention to threats, behavioral inhibition)
influences risk for fear/arousal disorders. Environmental risks are influenced by the genetic
liabilities (e.g., BD contributes to affiliation with deviant peers) and also contribute to the
etiology of internalizing and externalizing disorders. Some environmental factors (e.g., stressful
and traumatic events, negative parent–child relations, exposure to parents’ psychopathology)
contribute to risk for both externalizing and internalizing disorders, whereas other environmental
factors are likely to have a greater influence on either the externalizing factor (e.g., neighborhood
crime and availability of substances, deviant peer affiliation) or the internalizing factor (e.g.,
social rejection, peer conflict). At the lowest level of the hierarchy, unique genetic and
environmental risks specific to each disorder (SE; specific effects) explain why individuals with
the same general liability do not all have the same outcomes. The cumulative effects of geneenvironment interplay across development lead to the emergence of mental disorders, and the
hierarchical structure of genetically influenced liabilities contributes to covariance among
disorders and the observed pattern of comorbidity.

